What Will Happen When Rebates Go Away? Look At Authorized Generics

Recent launches by Lilly, Amgen and Gilead suggest list prices may decrease with the HHS proposal to disrupt the rebate system, but not as low as current net prices after rebates, according to pharmacy benefit experts.

lower-drug-prices

More from Pricing Debate

More from Market Access